Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Front Immunol ; 10: 1546, 2019.
Article in English | MEDLINE | ID: mdl-31354711

ABSTRACT

The global increase in autoimmunity, together with the emerging autoimmune-related side effects of cancer immunotherapy, have furthered a need for understanding of immune tolerance and activation. Systemic lupus erythematosus (SLE) is the archetypical autoimmune disease, affecting multiple organs, and tissues. Studying SLE creates knowledge relevant not just for autoimmunity, but the immune system in general. Murine models and patient studies have provided increasing evidence for the innate immune toll like receptor-7 (TLR7) in disease initiation and progression. Here, we demonstrated that the kinase activity of the TLR7-downstream signaling molecule, interleukin-1 receptor associated kinase 4 (IRAK4), is essential for mild and severe autoimmune traits of the Sle1 and Sle1-TLR7 transgenic (Sle1Tg7) murine models, respectively. Elimination of IRAK4 signaling prevented all pathological traits associated with murine lupus, including splenomegaly with leukocyte expansion, detectable circulating antinuclear antibodies and glomerulonephritis, in both Sle1 and Sle1Tg7 mice. The expansion of germinal center B cells and increased effector memory T cell phenotypes that are typical of lupus-prone strains, were also prevented with IRAK4 kinase elimination. Analysis of renal leukocyte infiltrates confirmed our earlier findings of an expanded conventional dendritic cell (cDC) within the kidneys of nephritic mice, and this was prevented with IRAK4 kinase elimination. Analysis of TLR7 at the protein level revealed that the expression in immune cells is dependent on the TLR7-transgene itself and/or autoimmune disease factors in a cell-specific manner. Increased TLR7 protein expression in renal macrophages and cDCs correlated with disease parameters such as blood urea nitrogen (BUN) levels and the frequency of leukocytes infiltrating the kidney. These findings suggest that controlling the level of TLR7 or downstream signaling within myeloid populations may prevent chronic inflammation and severe nephritis.


Subject(s)
Dendritic Cells/immunology , Interleukin-1 Receptor-Associated Kinases/metabolism , Kidney/pathology , Leukocytes/physiology , Lupus Erythematosus, Systemic/metabolism , Lupus Nephritis/metabolism , Macrophages/immunology , Toll-Like Receptor 7/metabolism , Animals , Antibodies, Antinuclear/blood , Cell Movement , Disease Models, Animal , Glomerulonephritis , Humans , Immunity, Innate , Interleukin-1 Receptor-Associated Kinases/genetics , Kidney/metabolism , Lupus Nephritis/genetics , Mice , Mice, Transgenic , Organ Specificity , Pre-B-Cell Leukemia Transcription Factor 1/genetics , Pre-B-Cell Leukemia Transcription Factor 1/metabolism , Signal Transduction , Toll-Like Receptor 7/genetics
2.
Arthritis Rheumatol ; 70(10): 1597-1609, 2018 10.
Article in English | MEDLINE | ID: mdl-29687651

ABSTRACT

OBJECTIVE: Toll-like receptors (TLRs) 7 and 9 are important innate signaling molecules with opposing roles in the development and progression of systemic lupus erythematosus (SLE). While multiple studies support the notion of a dependency on TLR-7 for disease development, genetic ablation of TLR-9 results in severe disease with glomerulonephritis (GN) by a largely unknown mechanism. This study was undertaken to examine the suppressive role of TLR-9 in the development of severe lupus in a mouse model. METHODS: We crossed Sle1 lupus-prone mice with TLR-9-deficient mice to generate Sle1TLR-9-/- mice. Mice ages 4.5-6.5 months were evaluated for severe autoimmunity by assessing splenomegaly, GN, immune cell populations, autoantibody and total Ig profiles, kidney dendritic cell (DC) function, and TLR-7 protein expression. Mice ages 8-10 weeks were used for functional B cell studies, Ig profiling, and determination of TLR-7 expression. RESULTS: Sle1TLR-9-/- mice developed severe disease similar to TLR-9-deficient MRL and Nba2 models. Sle1TLR-9-/- mouse B cells produced more class-switched antibodies, and the autoantibody repertoire was skewed toward RNA-containing antigens. GN in these mice was associated with DC infiltration, and purified Sle1TLR-9-/- mouse renal DCs were more efficient at TLR-7-dependent antigen presentation and expressed higher levels of TLR-7 protein. Importantly, this increase in TLR-7 expression occurred prior to disease development, indicating a role in the initiation stages of tissue destruction. CONCLUSION: The increase in TLR-7-reactive immune complexes, and the concomitant enhanced expression of their receptor, promotes inflammation and disease in Sle1TLR9-/- mice.


Subject(s)
Lupus Erythematosus, Systemic/immunology , Lupus Nephritis/immunology , Toll-Like Receptor 7/immunology , Toll-Like Receptor 9/deficiency , Up-Regulation/immunology , Animals , Antigens/immunology , Disease Models, Animal , Mice , RNA/immunology , Toll-Like Receptor 9/immunology
3.
Mech Ageing Dev ; 165(Pt A): 33-46, 2017 07.
Article in English | MEDLINE | ID: mdl-27614000

ABSTRACT

The presence of damaged and microbial DNA can pose a threat to the survival of organisms. Cells express various sensors that recognize specific aspects of such potentially dangerous DNA. Recognition of damaged or microbial DNA by sensors induces cellular processes that are important for DNA repair and inflammation. Here, we review recent evidence that the cellular response to DNA damage and microbial DNA are tightly intertwined. We also discuss insights into the parameters that enable DNA sensors to distinguish damaged and microbial DNA from DNA present in healthy cells.


Subject(s)
Bacteria/immunology , DNA Repair/immunology , DNA, Bacterial/immunology , Animals , Bacteria/genetics , DNA Repair/genetics , DNA, Bacterial/genetics , Humans , Inflammation/genetics , Inflammation/immunology , Inflammation/pathology
4.
Immunity ; 44(5): 1177-89, 2016 05 17.
Article in English | MEDLINE | ID: mdl-27178469

ABSTRACT

Self-DNA is present in the cytosol of many cancer cells and can promote effective immune rejection of tumor cells, but the mechanisms leading to the presence of cytosolic DNA are unknown. Here, we report that the cleavage of genomic DNA by DNA structure-specific endonuclease MUS81 and PARP-dependent DNA repair pathways leads to the accumulation of cytosolic DNA in prostate cancer cells. The number of nuclear MUS81 foci and the amount of cytosolic dsDNA increased in tandem from hyperplasia to clinical stage II prostate cancers and decreased at stage III. Cytosolic DNA generated by MUS81 stimulated DNA sensor STING-dependent type I interferon (IFN) expression and promoted phagocytic and T cell responses, resulting in type I and II IFN-mediated rejection of prostate tumor cells via mechanisms that partly depended on macrophages. Our results demonstrate that the tumor suppressor MUS81 alerts the immune system to the presence of transformed host cells.


Subject(s)
Autoantigens/metabolism , DNA-Binding Proteins/metabolism , DNA/metabolism , Endonucleases/metabolism , Prostatic Neoplasms/immunology , T-Lymphocytes/immunology , Animals , Autoantigens/immunology , Cell Line, Tumor , DNA/immunology , Humans , Interferon Type I/metabolism , Lymphocyte Activation , Male , Membrane Proteins/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Neoplasm Staging , Neoplasms, Experimental , Phagocytosis , Prostatic Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...